MAVRIC:经腹与经阴道宫颈环扎术的多中心随机对照试验
这项多中心随机对照试验将既往阴道环扎失败且有复发性妊娠丢失史的孕妇按1:1:1随机分配至经腹环扎、高位阴道环扎或低位阴道环扎组,主要结局为<32周分娩。经腹环扎组<32周早产率显著低于低位阴道环扎组(8% vs 33%;RR 0.23;95%CI 0.07-0.76;P=.0157)。高位与低位阴道环扎组早产率无差异。
要点
- 经腹环扎组<32周早产率8%(3/39)显著低于低位阴道环扎组33%(11/33),RR 0.23(95%CI 0.07-0.76;P=.0157)。
- 高位与低位阴道环扎组<32周早产率无差异:38%(15/39)vs 33%(11/33),RR 1.15(95%CI 0.62-2.16;P=.81)。
- 探索性分析中经腹环扎组胎儿丢失率3%(1/39)低于低位阴道环扎组21%(7/33),RR 0.12(95%CI 0.016-0.93;P=.02)。
核心结论
- 作者认为,对于既往阴道环扎失败的女性,经腹环扎是首选治疗,在降低早期早产和胎儿丢失风险方面优于低位阴道环扎,高位阴道环扎未带来此获益。
- 作者指出,需治疗人数足够低,可为此特定队列中经腹手术及所需的剖宫产提供依据。
研究设计与样本
- 多中心随机对照试验,139例招募女性中111例受孕者的数据纳入分析。
- 受孕前或妊娠<14周按1:1:1随机分配至经腹环扎组(39例)、高位阴道环扎组(39例)或低位阴道环扎组(33例)。
- 主要结局为妊娠<32周分娩。
主要发现
- 经腹环扎组<32周早产率8%(3/39) vs 低位阴道环扎组33%(11/33),相对危险度0.23(95%CI 0.07-0.76;P=.0157)。
- 预防1例早产需治疗人数为3.9(95%CI 2.32-12.1)。
- 高位阴道环扎组<32周早产率38%(15/39) vs 低位阴道环扎组33%(11/33),相对危险度1.15(95%CI 0.62-2.16;P=.81)。
- 无新生儿死亡发生。
- 探索性分析中,经腹环扎组胎儿丢失率3%(1/39) vs 低位阴道环扎组21%(7/33),相对危险度0.12(95%CI 0.016-0.93;P=.02);预防1例胎儿丢失需治疗人数为5.3(95%CI 2.9-26)。
临床怎么用
- 作者认为,经腹环扎是既往阴道环扎失败女性的首选治疗,优于低位阴道环扎,可降低早期早产和胎儿丢失风险。
- 作者指出,高位阴道环扎未带来此获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaginal cerclage (a suture around the cervix) commonly is placed in women with recurrent pregnancy loss. These women may experience late miscarriage or extreme preterm delivery, despite being treated with cerclage. Transabdominal cerclage has been advocated after failed cerclage, although its efficacy is unproved by randomized controlled trial. OBJECTIVE: The objective of this study was to compare transabdominal cerclage or high vaginal cerclage with low vaginal cerclage in women with a history of failed cerclage. Our primary outcome was delivery at <32 completed weeks of pregnancy. STUDY DESIGN: This was a multicenter randomized controlled trial. Women were assigned randomly (1:1:1) to receive transabdominal cerclage, high vaginal cerclage, or low vaginal cerclage either before conception or at <14 weeks of gestation. RESULTS: The data for 111 of 139 women who were recruited and who conceived were analyzed: 39 had transabdominal cerclage; 39 had high vaginal cerclage, and 33 had low vaginal cerclage. Rates of preterm birth at <32 weeks of gestation were significantly lower in women who received transabdominal cerclage compared with low vaginal cerclage (8% [3/39] vs 33% [11/33]; relative risk, 0.23; 95% confidence interval, 0.07-0.76; P=.0157). The number needed to treat to prevent 1 preterm birth was 3.9 (95% confidence interval, 2.32-12.1). There was no difference in preterm birth rates between high and low vaginal cerclage (38% [15/39] vs 33% [11/33]; relative risk, 1.15; 95% confidence interval, 0.62-2.16; P=.81). No neonatal deaths occurred. In an exploratory analysis, women with transabdominal cerclage had fewer fetal losses compared with low vaginal cerclage (3% [1/39] vs 21% [7/33]; relative risk, 0.12; 95% confidence interval, 0.016-0.93; P=.02). The number needed to treat to prevent 1 fetal loss was 5.3 (95% confidence interval, 2.9-26). CONCLUSION: Transabdominal cerclage is the treatment of choice for women with failed vaginal cerclage. It is superior to low vaginal cerclage in the reduction of risk of early preterm birth and fetal loss in women with previous failed vaginal cerclage. High vaginal cerclage does not confer this benefit. The numbers needed to treat are sufficiently low to justify transabdominal surgery and cesarean delivery required in this select cohort.
引用
- Shennan A, Chandiramani M, Bennett P, et al. MAVRIC: a multicenter randomized controlled trial of transabdominal vs transvaginal cervical cerclage. Am J Obstet Gynecol. 2019. PMID: 31585096. doi:10.1016/j.ajog.2019.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。